The Academy and other groups participated in an Oct. 4 meeting with CMS in which we successfully convinced the agency that the diabetes cost measure is not applicable to ophthalmology. Members who believe they have been incorrectly applied cost measures have until 8 p.m. ET Monday, Oct. 9, to submit a targeted review.